Related references
Note: Only part of the references are listed.Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis
Almut Meyer-Bahlburg et al.
BLOOD (2008)
Physiological promoters reduce the genotoxic risk of integrating gene vectors
Daniela Zychlinski et al.
MOLECULAR THERAPY (2008)
Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein
Deanna D. Nguyen et al.
GASTROENTEROLOGY (2007)
The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors
T. Higashimoto et al.
GENE THERAPY (2007)
Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS
Benoit Callendret et al.
VIROLOGY (2007)
Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients
S. Charrier et al.
GENE THERAPY (2007)
The Wiskott-Aldrich syndrome protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells
Michel H. Maillard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning
H. Bobby Gaspar et al.
MOLECULAR THERAPY (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression
A Schambach et al.
GENE THERAPY (2006)
Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation
L Dupré et al.
HUMAN GENE THERAPY (2006)
Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice
M Themis et al.
MOLECULAR THERAPY (2005)
A lentiviral vector encoding the human Wiskott Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice
S Charrier et al.
GENE THERAPY (2005)
Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response
L Westerberg et al.
BLOOD (2005)
Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE)
SM Kingsman et al.
GENE THERAPY (2005)
Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells
Y Calle et al.
JOURNAL OF PATHOLOGY (2004)
Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice
C Klein et al.
BLOOD (2003)
CRM1-dependent function of a cis-acting RNA export element
I Popa et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors
A Schambach et al.
MOLECULAR THERAPY (2000)
Share Paper
